Author Correction: Fructosamine is a valuable marker for glycemic control and predicting adverse outcomes following total hip arthroplasty: a prospective multi‑institutional investigation
Noam Shohat, Karan Goswami, Leigham Breckenridge and 5 more
Scientific Reports · 2021
doi:10.1038/s41598-021-94867-1 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
The original version of this Article contained an error in Table 2, where in columns “Total cohort (n = 1212)” and “Fasting plasma glucose ≥ 100 mg/dL (n = 423)”, the n values for ‘Normal fructosamine’ and ‘High fructosamine’ were accidently switched. The correct and incorrect heading rows appear below.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.